| SC 13G/A | 2024-02-14 | 683 Capital Management, LLC | Eiger BioPharmaceuticals, Inc. | 70,000 | 4.7% | EDGAR |
| SC 13G/A | 2024-02-14 | AMERIPRISE FINANCIAL INC | Eiger BioPharmaceuticals, Inc. | 7,505,539 | 16.9% | EDGAR |
| SC 13D/A | 2023-12-04 | Arkin Moshe | Eiger BioPharmaceuticals, Inc. | 4,481,126 | 10.1% | EDGAR |
| SC 13D | 2023-11-24 | Arkin Moshe | Eiger BioPharmaceuticals, Inc. | 4,482,126 | 10.1% | EDGAR |
| SC 13D/A | 2023-11-03 | Propel Bio Management, LLC | Eiger BioPharmaceuticals, Inc. | 4,391,432 | 9.9% | EDGAR |
| SC 13D | 2023-10-20 | Propel Bio Management, LLC | Eiger BioPharmaceuticals, Inc. | 4,367,100 | 9.9% | EDGAR |
| SC 13G/A | 2023-09-28 | Propel Bio Management, LLC | Eiger BioPharmaceuticals, Inc. | 4,823,938 | 10.9% | EDGAR |
| SC 13G | 2023-08-15 | Propel Bio Management, LLC | Eiger BioPharmaceuticals, Inc. | 2,392,167 | 5.4% | EDGAR |
| SC 13G/A | 2023-07-07 | BlackRock Inc. | Eiger BioPharmaceuticals, Inc. | 937,125 | 2.1% | EDGAR |
| SC 13G/A | 2023-04-18 | Arkin Moshe | Eiger BioPharmaceuticals, Inc. | 4,482,126 | 10.2% | EDGAR |
| SC 13G/A | 2023-04-10 | AMERIPRISE FINANCIAL INC | Eiger BioPharmaceuticals, Inc. | 8,028,922 | 18.2% | EDGAR |
| SC 13G/A | 2023-02-14 | 683 Capital Management, LLC | Eiger BioPharmaceuticals, Inc. | 3,115,000 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-09 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Eiger BioPharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-06 | BlackRock Inc. | Eiger BioPharmaceuticals, Inc. | 2,855,690 | 6.5% | EDGAR |
| SC 13G/A | 2023-02-02 | Arkin Moshe | Eiger BioPharmaceuticals, Inc. | 2,713,002 | 6.2% | EDGAR |
| SC 13G/A | 2023-01-10 | AMERIPRISE FINANCIAL INC | Eiger BioPharmaceuticals, Inc. | 5,444,756 | 12.4% | EDGAR |
| SC 13G/A | 2022-05-11 | AMERIPRISE FINANCIAL INC | Eiger BioPharmaceuticals, Inc. | 7,590,126 | 17.6% | EDGAR |
| SC 13G | 2022-05-02 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Eiger BioPharmaceuticals, Inc. | 2,800,000 | 8.0% | EDGAR |
| SC 13G | 2022-03-08 | Arkin Moshe | Eiger BioPharmaceuticals, Inc. | 1,826,226 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-14 | 683 Capital Management, LLC | Eiger BioPharmaceuticals, Inc. | 3,300,000 | 9.7% | EDGAR |